Crowdfunding

Donate Via Our New Donor App: Receive Matching Benefits Of Up To ₹1000 For Every Unique Donor

Donate via our Donation App and receive up to ₹1000 as matching benefits.

We have a gift for your kindness!

Claim Gift
LIVE


Support Master Mahansh

ImpactGuru has waived off part of its fee for this cause

Save 1 Y/O Mahansh from Spinal Muscular Atrophy Type 2

Save 1 Y/O Mahansh from Spinal Muscular Atrophy Type 2

RT
Campaigner Details
Impactguru Verified

Ravi Tejavath
Hyderabad Telangana Contact
MM
Beneficiary Details
Impactguru Verified

Master Mahansh
Child of Ravi Tejavath
Ongoing Treatment at
Rainbow Children's Hospital and BirthRight, Karkhana, Secunderabad, Best Maternity Hospital , Secunderabad

of $ 1,882,353

2,723 Donors
Funds will be transferred for patient's treatment
Impactguru
Every social media share can bring $80

Donate via UPI

Donate via Paytm/Google Pay/PhonePe


Impactguru
supportmahansh@yesbankltd
Donations made through this fundraiser and UPI ID will be securely deposited into Impact Guru’s bank account for the patient’s treatment. This UPI ID is not associated with any individual’s or family’s personal bank account.

Scan the QR code from the app and make payment


Donations made through this fundraiser and UPI ID will be securely deposited into Impact Guru’s bank account for the patient’s treatment. This UPI ID is not associated with any individual’s or family’s personal bank account.

Acknowledge Via Donation App

Use this code CAM5ZMNML to get an additional contribution of up to ₹1000 by acknowledging your transaction through the Donation App.

RT
Campaigner Details
Impactguru Verified

Ravi Tejavath
Hyderabad Telangana | Contact
MM
Beneficiary Details
Impactguru Verified

Master Mahansh
Child of Ravi Tejavath
Ongoing Treatment at
Rainbow Children's Hospital and BirthRight, Karkhana, Secunderabad, Best Maternity Hospital , Secunderabad

Latest Update


Dear Donors,

Baby Mahansh has Spinal Muscular Atrophy (a rare genetic illness that causes severe muscle weakness and regression).

He is struggling to sit, crawl, stand, or walk, and is currently undergoing physiotherapy to prevent further loss of strength.

Doctors have advised urgent treatment with Risdiplam and Zolgensma, medicines that can slow down the disease and help him regain muscle power.

The cost of treatment is around ₹16 crore, far beyond the family’s means. They have already taken loans and spent lakhs on his care.

Your support can give Mahansh the chance to sit, stand, and one day walk with joy. Please donate and share his story to help save his life.

- Team ImpactGuru

Story


“I hold my son in my arms and hope that I will soon watch him grow up healthy.” - Ravi Tejavath, father.



As a farmer from a small village in Telangana, I always wondered about the life I would give my children. After my daughter was born, we were blessed with the gift of a son, my 1-year and 3-month-old Baby Mahansh. I imagined a life where he goes to school, laughs with us and runs around with his friends but…My wife and daughter look at me with tears in their eyes saying, “When is Mahansh going to be okay?”


What troubles my son?

It began 9 months ago, my son Mahansh was losing weight and struggling to sit, crawl, walk and could not even stand. The doctors at Rainbow Children's Hospital and BirthRight, Karkhana in Secunderaba,d said to us, “Your son is facing severe motor delay with motor regression and weakness.”


By the 10th of June 2025, my son was diagnosed with Spinal Muscular Atrophy Type 2.


Spinal Muscular Atrophy (SMA) type 2, also known as intermediate SMA, is a life-threatening genetic condition causing progressive muscle weakness that typically begins between 6 and 18 months of age, allowing affected children to sit independently but not walk.


What is the treatment required?

My baby needs a life-saving drug Risdiplam and Zolgensma. As of now, he is undergoing physiotherapy but the doctors say, “The imported medicine can save his life but he needs it as soon as possible.”


Risdiplam is an oral medication approved for treating Spinal Muscular Atrophy (SMA) Type 2, working by increasing the production of the essential Survival Motor Neuron (SMN) protein by modifying SMN2 gene splicing.


Zolgensma is a one-time, intravenous (IV) gene therapy for Spinal Muscular Atrophy (SMA) that targets the genetic root cause of the disease.

It would be a dream come true to see my son recover from SMA and someday grow up to be a doctor. But for now, my son needs support to fight and I turn to you.


We have already taken loans on interest and spent more than 1.20 lakh rupees but Mahansh needs more support. The life-saving drug costs ₹16 cr, It is you who can help my son gain the strength to sit, stand and soon walk with ease. Help him by donating now.




How can you help my baby?

Donate to his treatment.

By donating, you help ensure that he receives the treatment that saves his life.


Share his story with your family and friends.

By sharing his story with your loved ones and friends, you will help to amplify his voice to those who care and are willing to donate.


****


Disclaimer - 

SMA is a progressive disease that causes muscles to weaken over time. To prevent further deterioration and slow the progression,the child urgently needs the drug Risdiplam to preserve muscle function only if it is prescribed by the doctor, While the fundraising for Zolgensma is underway, starting Risdiplam immediately is a critical step to safeguard the child’s life and preserve muscle function.


కేవలం 1 సంవత్సరం 3 నెలల వయసులో, బేబీ మహన్ష్ స్పైనల్ మస్కులర్ అట్రోఫీ టైప్ 2 తో పోరాడుతున్నాడు

తన చిన్న శరీరంలో బలాన్ని పొందడానికి అతనికి ఖరీదైన రిస్డిప్లామ్ మరియు జోల్జెన్స్మా అవసరం

మీ దాతృత్వం అతనికి సహాయపడుతుంది

ఇప్పుడే దానం చేయండి


నా బిడ్డకు మీరు ఎలా సహాయం చేయగలరు?

అతని చికిత్సకు విరాళం ఇవ్వండి.

దానం చేయడం ద్వారా, అతని ప్రాణాలను కాపాడే చికిత్స అతనికి అందేలా మీరు సహాయం చేస్తారు.


అతని కథను మీ కుటుంబం మరియు స్నేహితులతో పంచుకోండి.

మీ ప్రియమైనవారు మరియు స్నేహితులతో అతని కథను పంచుకోవడం ద్వారా, శ్రద్ధ వహించే మరియు దానం చేయడానికి సిద్ధంగా ఉన్నవారికి అతని స్వరాన్ని విస్తృతం చేయడానికి మీరు సహాయం చేస్తారు.

The goal amount of the campaign may be higher than the attached estimates to address and aid the post-hospitalization expenses/contingencies including but not limited to prolonged medication, diagnostics, rehabilitation therapies, and follow-up doctor visits/consultations which vary from disease to disease.
NO INFLUENCE DECLARATION
Impact Guru does not influence / control the decision of the campaigner / patient with respect to choice of hospital / doctor / healthcare treatment or the cost / estimate of any such treatment. Such decision is in entirety of campaigner / patient / beneficiary and / or their family members without any interference and / or say of Impact Guru. Impact Guru is absolved of any liability in respect thereof.
LANGUAGE OF STORY/STATEMENT DECLARATION
The language, story, facts mentioned on this fundraising page is in entirety statements / opinions / thoughts shared by the campaigner / beneficiary or persons authorised on their behalf and shall not be construed as statement / thoughts / opinions of or on behalf of Impact Guru.
TREATMENT COST ESTIMATES
Impact Guru has no control over the cost estimates provided by hospitals / clinics / pharmaceutical companies etc. The cost estimates vary depending on the city and / or hospital where the patient is under treatment, professional fees of the treating doctors, drugs / medicines / therapies chosen for treatment by patient or patient’s family at their own discretion including but not limited to unique medical conditions / circumstances pertaining to each patient.
UTILIZATION OF FUNDS
In the rare scenario of surplus funds remaining within the fundraising campaign due to any of the following circumstances:
i) Completion of the Patient's treatment; ii) Receipt of requisite funding for the Patient from alternative sources; iii) Eligibility of the Patient for free treatment under any scheme or the receipt of free treatment by other means; iv) Demise of the Patient; v) Fulfilment of the fundraising campaign's objectives; vi) Termination of the fundraising campaign for any reason; vii) Reduction in the cost of the drug/therapy required for SMA treatment; viii) Prescription of an alternative therapy for the Patient's treatment
Impact Guru shall ensure that such surplus funds are allocated for the following purposes:
i) Provision of alternative drug therapy treatments as prescribed by the attending physician for the Patient/s (if applicable). Such utilization may span across multiple years, as SMA therapies/treatments typically entail long-term, recurring costs; ii) If surplus funds persist even after the aforementioned allocation, they shall be employed to assist other patients on Impact Guru in their life-saving treatment, with the objective of maximizing social impact; iii) donors of the fundraising campaign at the sole discretion of Impact Guru may be offered the option to claim a pro-rata refund of surplus funds.
PATIENT DEATH UPDATE
Upon the death of the patient, the Campaigner / close relative / POC on behalf of the patient shall be duty bound to inform Impact Guru immediately within two (2) hours of such occurrence and turn off the donations tab (through the internal access granted) on the campaign on Impact Guru Platform in order to stop fundraising on the campaign. In the event Campaigner or authorised/designated POC on behalf of the patient fails to do so and campaign continues raising funds due to such non-information/non action, the Campaigner or authorised/designated POC on behalf of the patient shall be personally liable any consequences thereof; further, Impact Guru shall be disclaimed of all the liabilities occurring with respect to such post death fundraising and the such liability in entirety shall accrue on Campaigner or authorised/designated POC on behalf of the patient. In the event of death of the patient, Impact Guru’s Patient Death Policy at Terms Of Use shall apply.
Documents

Updates(3)


#1 (18 Sep, 2025) - From Ravi Tejavath

Dear Donors,

Baby Mahansh has Spinal Muscular Atrophy (a rare genetic illness that causes severe muscle weakness and regression).

He is struggling to sit, crawl, stand, or walk, and is currently undergoing physiotherapy to prevent further loss of strength.

Doctors have advised urgent treatment with Risdiplam and Zolgensma, medicines that can slow down the disease and help him regain muscle power.

The cost of treatment is around ₹16 crore, far beyond the family’s means. They have already taken loans and spent lakhs on his care.

Your support can give Mahansh the chance to sit, stand, and one day walk with joy. Please donate and share his story to help save his life.

- Team ImpactGuru

#2 (11 Sep, 2025) - From Ravi Tejavath

Dear Donors,

Baby Mahansh struggles to sit, stand, crawl and even walk. At just 1 year and 3 months old, he needs the life-saving Zolgensma and Risdiplam drugs to fight Spinal Muscular Atrophy Type 2 (SMA) a rare genetic condition that is causing him motor delay and motor regression. Your generosity toward his treatment is life-saving. Donate and share his story as much as you can. Help him receive this time-limited treatment soon.

#3 (08 Sep, 2025) - From Ravi Tejavath

Dear Donors,

Mahansh is currently at home and on a nebulizer. The doctor has advised starting Risdiplam immediately, as it is vital for his treatment. He is also on regular medicines and syrup, but his condition is concerning since he is now running a fever.

We humbly request your continued support to help arrange Risdiplam at the earliest. Your generous contributions can make a big difference in Mahansh’s fight for recovery.

Comment



Fundraisers for This Cause




Touch more lives with your Kindness !

playstore
X

Access and manage fundraisers at your fingertips!

Get important fundraising tips, a personalized dashboard and real-time updates with ImpactGuru’s new and improved crowdfunding app.

qrcode qrcode

Scan the QR code to download the app

mobile-out-image
mobile-inside-image